Navigation Links
Bionovo to Present at the JMP Securities Healthcare Conference
Date:9/21/2010

EMERYVILLE, Calif., Sept. 21 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development company focused on the unmet needs in women's health and oncology, today announced that Dr. Isaac Cohen, O.M.D., Chairman and Chief Executive Officer, will be presenting at the JMP Securities Healthcare Conference at 4:00 p.m. ET on Tuesday, September 28, 2010. The event will be held at the New York Palace hotel in New York City.

Interested parties can access a live audio webcast of the presentation by visiting http://bionovo.com/investors/events or at http://www.wsw.com/webcast/jmp11/bnvi/. A replay of this webcast will also be available for 90 days following the conference at http://bionovo.com/investors/events.

About Menerba

Menerba is an oral, botanical-derived drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause. Menerba is an estrogen receptor beta (ER-b) selective drug, developed as an alternative to the products currently on the market, which have been shown to increase the risk for breast and uterine cancers. Clinical tests conducted thus far, following the specific guidance of the FDA, have indicated that Menerba is effective and safe.

About Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bionovo to Present at Cambria Capital Investor Meeting
2. Bionovo Receives Positive Guidance from FDA on Menerba®
3. Bionovo Announces Reverse Stock Split
4. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
6. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
7. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
8. Bionovo Announces 2009 Highlights and Year-End Financial Results
9. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
10. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
11. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... MOUNTAIN VIEW, Calif. , July 22, 2014 ... magnetic resonance imaging (MRI) market, Frost & Sullivan ... Award for Product Leadership. Siemens Healthcare,s FREEZEit solution, ... addresses the need for robust and motion-insensitive imaging. ... has boosted the evolution of body MRI imaging ...
(Date:7/22/2014)... England , July 22, 2014 Elekta ... announced today that The Christie NHS Foundation Trust ( ... will join a consortium whose mission is to develop ... (MRI) guided radiation therapy system. Such a system would, ... visualization of cancer targets. "The Christie ...
(Date:7/22/2014)... Ariz. , July 22, 2014  A ... of a SynCardia temporary Total Artificial ... Rochester,s Strong Memorial Hospital with the Freedom® portable ... Fontana, a 64-year-old retiree from a ... decades. He managed the condition with medications, an ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... FORD, Pa., March 29, 2012 Endo (Nasdaq: ENDP ... Bihl, will step down as head of the Endo devices operating ... successor, a comprehensive executive search has been initiated. Mr. ... acquisition of AMS and was named President and Chief Executive Officer ...
... VIEW, Calif., March 29, 2012  Based on its ... market, Frost & Sullivan recognizes Sensear with the ... Product Differentiation Excellence for its "high-noise communication" devices, ... products protect hearing while still enabling the user ...
Cached Medicine Technology:Endo Announces Departure of American Medical Systems President 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
(Date:7/22/2014)... 22, 2014 Thought Technology's ... of simple tools, designed to help clinicians do biofeedback ... no experience with biofeedback. The tools in the suite ... elucidate any abnormal patterns to teach them to recuperate ... world, we are familiar with stress and its negative ...
(Date:7/22/2014)... HIV researchers from Aarhus University and Aarhus University Hospital ... activate hidden HIV. The researchers found that the anti-cancer ... between 2.1 and 3.9 times above normal and that ... levels in five out of six patients with HIV ... were presented today as breaking news at the annual ...
(Date:7/22/2014)... the University of Murcia have studied the changes ... a personality trait that causes difficulties in inhibiting ... and leads to unplanned actions without considering the ... indicator for predicting the risk of behavioural problems. ... the University of Murcia analyses whether the connectivity ...
(Date:7/22/2014)... foreign vocabulary, our brains hold a seemingly endless ... older, our ability to learn and remember new ... Prof Dr Antonio Del Sol Mesa from the ... of Luxembourg and Dr Ronald van Kesteren of ... mechanisms of this cognitive decline using latest high-throughput ...
(Date:7/22/2014)... Expert Publishing (ExPub), a ... the launch of PoisonEXPERT™ , a resource ... employed by organizations that use or manufacture large ... impact of chemicals on their employees and the ... information and medical protocols that allows users to ...
Breaking Medicine News(10 mins):Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 3Health News:Anti-cancer drug kicks HIV out of hiding 2Health News:Children's impulsive behaviour is related to their brain connectivity 2Health News:Rigid connections: Molecular basis of age-related memory loss explained 2Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3
... penis transplant, but were forced to remove it after the ... had lost his penis in an accident and was unable ... ,Doctors had attached a 10cm penis to the 44-year-old patient ... month's journal European Urology. 'Because of a severe psychological problem ...
... in Thiruvananthapuram said that there was no need to panic ... fever were reported in the city.// ,Health authorities said ... continue to pelt the state. The chikungunya scare so far ... not be confined to some pockets as mosquitoes are increasing ...
... for the treatment of mild to moderate obstructive ... The effectiveness of palatal implants for treatment of ... demonstrated in a number of clinical studies. Primarily, ... in apnea hypopnea index (AHI) as measured by ...
... cost the global economy up to $2 trillion or 4.8 ... said on Sunday.// ,In a worst-case scenario, 70 million ... the virus that had spread beyond East Asia to Europe, ... be the worst hit, with mortality rates double of those ...
... with now - a sharp rise in HIV/AIDS cases. While ... state, unofficial estimates peg the number at 25,000.// ... Features. The northern state lies in a low prevalence risk ... at 0.95 percent and among the low-risk groups at 0.06 ...
... be lost in several ways, not all may be healthy. ... is one of the healthy ways to lose weight.// ,The ... has found that eating high-fiber cereals not only help to ... magnesium and vitamin B-6. ,The study sponsored by Kraft, Dr. ...
Cached Medicine News:Health News:Palatal Implant Procedure Proven Effective in Eliminating Snoring 2Health News:Palatal Implant Procedure Proven Effective in Eliminating Snoring 3Health News:Kashmir Grapples with Growing AIDS 2Health News:Kashmir Grapples with Growing AIDS 3Health News:Weight Loss Healthier with a Diet of Whole Grain Cereals 2
... In certain hernia and soft tissue ... fascial defects, it is sometimes necessary ... one surface, while minimizing tissue attachment ... a soft, conformable, ePTFE sheet material ...
... Bard Dulex mesh is a dual-sided ePTFE ... side is a micro-porous structure designed to minimize ... side is a macro-porous structure designed to promote ... size of approximately 800 microns, which is nearly ...
... mesh is the first polypropylene mesh ... Visilex mesh directly addresses the critical ... specifically, it delivers maximum visibility, enhanced ... after insertion through the trocar.,Visilex mesh ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: